Rita Greco

Ospedale Sant'Anna — Italy

Medicine · Health Sciences

29h-index2.5kcitations81works0.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmacological Effects and Toxicity Studies(12), Epilepsy research and treatment(11), Antibiotic Resistance in Bacteria(5), Immune Cell Function and Interaction(4), Cytokine Signaling Pathways and Interactions(4)

Publications81 total

A Case of <i>Nocardia kroppenstedtii</i> Infection Successfully Treated With a Multidisciplinary Approach
Case Reports in Infectious Diseases·2025Open Access
Combined analysis of genome-wide DNA methylome and transcriptome reveals the first epigenetic-based antibiotic-resistance mechanism in Acinetobacter baumannii
Discover Bacteria.·2024· 1 citedOpen Access
Whole Genome Sequence Dataset of Mycobacterium tuberculosis Strains from Patients of Campania Region
Scientific Data·2024Open Access
BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression
Journal for ImmunoTherapy of Cancer·2022· 37 citedOpen Access
Diagnostic and infection control strategies for Clostridioides difficile infections in a setting of high antimicrobial resistance prevalence.
PubMed·2021· 4 cited
Isatuximab Acts Through Fc-Dependent, Independent, and Direct Pathways to Kill Multiple Myeloma Cells
Frontiers in Immunology·2020· 110 citedOpen Access
Some Shape, Durability and Structural Strategies at the Conceptual Design Stage to Improve the Service Life of a Timber Bridge for Pedestrians
Applied Sciences·2020· 6 citedOpen Access
Volume optimization of end-clamped arches
Hormigón y Acero·2020
Pan-TGFβ inhibition by SAR439459 relieves immunosuppression and improves antitumor efficacy of PD-1 blockade
OncoImmunology·2020· 53 citedOpen Access
Abstract 2966: Isatuximab-induced multiple myeloma cell killing through effector functions is dependent on CD38 expression and complement inhibitors
Cancer Research·2019· 3 cited
Abstract 2790: The anti-TGFβ neutralizing antibody, SAR439459, blocks the immunosuppressive effects of TGFβ and inhibits the growth of syngeneic tumors in combination with anti-PD1
Cancer Research·2018· 5 cited
Elizabethkingia meningosepticum: an emerging nosocomial pathogen in a critical patient with septicaemia
Microbiologia medica·2017Open Access
Abstract 4282: All-trans retinoic acid enhances the effector functions of the anti-CD38 antibody SAR650984
Cancer Research·2015
Combination of PIM and JAK2 inhibitors synergistically suppresses cell proliferation and overcomes drug resistance of myeloproliferative neoplasms
Oncotarget·2014· 31 citedOpen Access
Abstract 2435: Anticipating clinical resistance to SAR302503, a JAK2 inhibitor in clinical development for the treatment of myelofibrosis.
Cancer Research·2013· 1 cited
Abstract 4406: CARD11 is critical for in vitro and in vivo growth of ABC-DLBCL cells.
Cancer Research·2013
Abstract LB-294: Determination of <i>JAK2</i>V617F allele burden in a phase II study of patients with myelofibrosis treated with SAR302503 using a sensitive and robust allele-specific qPCR assay.
Cancer Research·2013· 1 cited
Abstract 4553: Design and validation of a screening strategy for the identification of novel inhibitors of wild type and mutant CARD11 mediated BCR/NF-κB signaling.
Cancer Research·2013
Abstract 1796: SAR302503: A Jak2 inhibitor with antitumor activity in solid tumor models
Cancer Research·2012· 4 cited
Acidic Mammalian Chitinase Is Not a Critical Target for Allergic Airway Disease
American Journal of Respiratory Cell and Molecular Biology·2011· 35 cited
page 1 of 5Next →

Frequent Co-authors

Alberto Verrotti(17), Francesco Chiarelli(15), G Morgese(11), Giovanna Donnarumma(6), Piera Valenti(6), Adone Baroni(6), Lori Fitz(5), Dmitri Wiederschain(5), Maria Antonietta Tufano(5), Giuseppe Latini(4), Emma Altobelli(4), Divya Chaudhary(3), Robert Czerwiński(3), Maria Ajello(3), Giovanni Antonini(3), Hongjing Qu(3), Jack Pollard(3), Eleonora Ruocco(3), Iole Paoletti(3), F Corrado(3)